Background: Most prostate cancer-related deaths result from metastasis. CXCR4 and CCR2 are known to govern cellular processes resulting in cell migration, proliferation and survival. These receptors are expressed at low levels on normal prostate cells and are highly expressed on malignant and metastatic prostate cancer cells. Signaling of these receptors is relatively well understood, but processes governing their expression at the cell membrane are not. PC3 prostate cancer cells were used to demonstrate the importance of various Rab GTPases on cell surface expression and signaling of CXCR4 and CCR2, along with the CXCR4/CCR2 heterodimer. Methods: PC3 prostate cancer cells were transfected with select Rab GTPase wild-type and dominant negative constructs. Effects of each Rab GTPase on endogenous cell surface expression of the individual receptors, along with the overexpressed CXCR4/ CCR2 heterodimer, were determined by biotin-streptavidin cell surface assays. These results were corroborated by assessing signal transduction, measured by focal adhesion kinase (FAK) activation. Conclusion: Rab GTPases required for cell surface expression and signal transduction of CXCR4 or CCR2 differ from those required for the CXCR4/CCR2 heterodimer. Determining trafficking regulators of two key receptors involved in the metastatic transition may identify new targets to restrict expression of chemokine receptors employed during metastasis.
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characterized. The expression of CCR2 and CXCR4 at the plasma membrane is of interest to cancer researchers because their respective ligands are able to cause cancer cell migration, and possibly increase the likelihood and severity of metastasis. Therefore, the pathways governing their cell surface expression as both individual receptors and heterodimers are significant processes that warrant investigation to help understand cancer progression and subsequent metastasis. Characterization of the trafficking pathways used by chemokine receptors CXCR4 and CCR2 for their expression at the plasma membrane could help identify targets that could be used to restrict their expression at the cell surface. Individual Rab GTPases have been used to control transport steps associated with receptor transport from the endoplasmic reticulum (ER) to plasma membrane [30] [31] [32] . Specifically, effects of the dominant-negative Rab1, 2, 6, 8 and 11 isoforms were investigated because these Rab GTPases are known to play a role in the transport of GPCRs from the ER to the plasma membrane [30] [31] [32] . We demonstrate how different Rab GTPases regulate anterograde trafficking of endogenous CXCR4 and CCR2 receptors and overexpressed CXCR4/CCR2 heterodimers in a prostate cancer cell line. Although there are a wide variety of signal transduction cascades initiated by activation of GPCRs [33] , we chose to concentrate on how the activation of focal adhesion kinase (FAK), a non-receptor tyrosine kinase that has been shown as a key regulator of cell growth, survival and migration -key processes often altered in cancer progression [34] , is affected by anterograde trafficking of chemokine receptors.
Materials and Methods
Reagents PC3 cells were obtained from ATCC (Manassas, VA). Fetal bovine serum and Lipofectamine 2000 were purchased from Invitrogen (Etobicoke, ON, Canada). Dulbecco's Modified Eagle's Medium (DMEM) High Glucose, monoclonal anti-FLAG antibody, protein A-Sepharose and all chemicals were from Sigma-Aldrich (Oakville, ON, Canada). Laemmli sample buffer was from BioRad (Mississauga, ON, Canada) and BioTrace TM nitrocellulose transfer membrane was from Pall Corporation (Port Washington, NY, USA). Supersignal West Femto Maximum Sensitivity Substrate, EZ-link Sulfo-NHS-LC-Biotin and Streptavidin Agarose Resin were from Pierce Biotechnology (Rockford, IL, USA). SDF-1α, MCP-1 and monoclonal anti-β actin were from Abcam (Toronto, ON, Canada). Polyclonal anti-GFP, monoclonal anti-c-myc, monoclonal anti-CCR2, polyclonal anti-fusin (C-20; anti-CXCR4), monoclonal anti-pFAK and horseradish peroxidase (HRP)-conjugated secondary antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Polyclonal anti-FAK was from Biovision (Milpitas, CA, USA).
Constructs
CCR2 and CXCR4 receptors were purchased from the Missouri University of Science and Technology cDNA resource center and subcloned into a pcDNA3.1 vector containing the N-(venus1) or C-terminal (venus2) fragment of venus yellow protein as described in [35] . Wild-type and dominant negative Rab GTPases were constructed as detailed in [32] .
Cell culture and transfection
The PC3 cell line was maintained in DMEM High Glucose supplemented with 10% fetal bovine serum. Cells were plated in 6-well plates and subsequently transfected with cDNA using Lipofectamine 2000 according to manufacturer's instructions. Experiments were normally conducted 48 h post-transfection, following 24 h of serum deprivation.
Fluorescence Microscopy
Twenty four hours following transfection of PC3 cells with CXCR4 V1 and CCR5 V2, cells were harvested and seeded onto laminin-coated cover slips and incubated at 37°C for four 4 h. PC3 cells were then fixed using 3% (w/v) paraformaldehyde in PBS, pH 7.4 for 20 min at room temperature. Cover slips were then rinsed with PBS and mounted onto glass slides with 0.4% 1,4-diazabicyclo{2.2.2}octane/glycerol medium 
SDS-PAGE gel electrophoresis and western blotting
PC3 cells were treated with SDF-1α or MCP-1 for 15 min at 37˚C, or remained unstimulated. Cells were lysed in radioimmume precipitation assay (RIPA) buffer (50 mM Tris (pH 7.4), 100 mM MgCl 2 , 150 mM NaCl, 0.5% sodium deoxycholate, 1% Nonidet P-40, 0.1% SDS, Roche COMPLETE protease inhibitor tablet) and placed in a dry bath at 65˚C for 5 min prior to being resolved by SDS-PAGE and transferred to nitrocellulose membranes. Immunoblots were probed with primary antibodies overnight and then HRP-conjugated secondary antibodies. Immunoblots were visualized with Western Lightning Plus-ECL Chemiluminescence Substrate. ImageJ 4.3 software (NIH) was used to calculate band densities of the immunoblots.
Biotin-streptavidin cell surface assay PC3 cells were transfected with a venus-tagged receptor pair, as well as a Rab construct, and harvested after 48 h. Cells were washed with PBS prior to incubation with 0.9 mM EZ-link Sulfo-NHS-LC-Biotin for 30 min. Samples were washed with 100 mM Glycine-PBS and lysed with RIPA buffer. Supernatants were incubated overnight with Streptavidin Agarose Resin. Three washes with RIPA buffer were completed before beads were incubated in SDS-PAGE sample buffer with 2.8 M DTT for 1 h at room temperature to elute bound proteins. Immunoblots were probed with anti-GFP antibody, anti-CCR2 or anti-CXCR4, as well as a horseradish-peroxidase-conjugated secondary antibody.
Co-immunoprecipitation 100 µl of RIPA buffer was used to lyse cells and samples were pre-cleared with 10 µl of protein-A sepharose beads with BSA and placed to nutate for 30 minutes at 4°C. Lysates were then clarified by centrifugation at 13000 RPM for 15 minutes at 4°C. Samples were incubated with anti-CXCR4 antibody for 30 minutes at 4°C. The subsequent protein-antibody complex was precipitated with 50 µl of protein-A sepharose beads at 4°C to precipitate proteins of interest. Samples were then washed with RIPA and proteins were eluted with 100 µl of Laemmli sample buffer containing β-mercaptoethanol. For cell lysis analysis, 30 µl of the supernatant that resulted from centrifugation was added to 30 µl of Laemmli sample buffer containing β-mercaptoethanol. Samples were processed with SDS-PAGE and immunoblots were probed with anti-CCR2 and anti-CXCR4 antibodies.
Results and Discussion

CXCR4 and CCR2 expression in PC3 cells
Constant improvements have been made not only to the diagnosis, but also to the treatment of prostate cancer [36] . Unfortunately, metastatic prostate cancer is still associated with poor prognosis [36, 37] . PC3 cells have demonstrated higher metastatic potential compared to other cell lines [38] . Previous studies have shown endogenous expression of the chemokine GPCRs CXCR4 [12] and CCR2 [18] in the PC3 cells, suggesting that these receptors may contribute to heightened malignancy of the cancer. Anti-CXCR4 antibodies also significantly impaired the migration and invasive potential of PC3 cells [39] . For these reasons, the PC3 human prostate cancer cell line was chosen for the following experiments. Endogenous levels of CXCR4 and CCR2 expressed endogenously on PC3 cells were evaluated using western blotting; the results are shown in Figure 1A and IB. It has been demonstrated that these receptors form both homodimers and heterodimers, and that ligands interact differentially with the heterodimer than the individual receptors [25, 29] . As shown by co-immunoprecipitation, endogenous CXCR4 can co-precipitate with endogenous CCR2 in the PC3 cell line (Fig. 1A) . Additionally, the same experiment was done in the opposite order; immunoprecipitating CCR2 and blotting against CXCR4 yields the same result (Fig.  1B) . Therefore, these two chemokine receptors form a signaling complex with each other at endogenous expression levels in PC3 cells. Signaling resulting from receptor activation of
cells through the formation of a fluorescent molecular complex. Two protein fragments, each of which is unable to fluoresce individually, fuse and form a fluorescent protein [40] . Most often, variants of yellow fluorescent protein are used such that two halves are created -an N-terminal and C-terminal fragment [40] . In this study, the Venus variant of yellow fluorescent protein was used and either an N-terminal (Venus1, the first 157 amino acids of Venus) or C-terminal (Venus2, amino acids 158 to 238 of Venus) fragment was coupled to a receptor.
When not reconstituted, each singular Venus fragment is unable to emit fluorescence and cannot bind to an anti-GFP antibody. Upon dimerization of receptors coupled to each Venus fragment, Venus1 and Venus2 form a functional Venus that emits fluorescence and can bind to an anti-GFP antibody (Fig. 1C) . Figure 1D and 1E show the relative fluorescence levels of various chemokine receptor dimer combinations, and fluorescence microscopy of the CXCR4/CCR2 heterodimer pairing used in the study.
Rab expression
Anterograde trafficking is a critical step in the regulation of GPCR signaling; the assembly and trafficking of receptor complexes depends on a number of factors, including Rab GTPases. It has been shown that anterograde trafficking pathways of multiple GPCRs can be altered by transfection with dominant negative forms of Rab GTPases in numerous cell lines, including HEK293s [30, 32] , Jurkats [41] and cardiac myocytes [31] . Here, we sought to investigate how affecting receptor trafficking with various Rab GTPases could alter plasma membrane expression of endogenous CXCR4 and CCR2, as well as the CXCR4/CCR2 heterodimer. PC3 cells were transfected with myc-or flag-tagged WT or dominant negative Rab GTPases constructs for 48 h, lysed and loaded on SDS-PAGE. Figure 2 shows that expression levels for each Rab GTPase were similar among all constructs when transfected into PC3 cells. Therefore, variations in expression levels of the chemokine receptors at the plasma membrane does not originate from various levels of expression of the GTPases, but rather from the regulation of receptor trafficking by the GTPases. Figure 2 also indicates that total endogenous CXCR4 and CCR2 levels are not changed following transfection with Rab GTPase WT or dominant negative constructs.
CXCR4 trafficking pathway
In order to study the effects of Rab GTPase dominant negative mutants on the trafficking of endogenous CXCR4 and CCR2 and overexpressed heterodimeric complexes to the plasma membrane, we decided to examine cell surface expression of these receptors. PC3 cells were transfected with various Rab GTPase isoforms (WT or dominant negative). Cell surface expression of CXCR4 was measured 48 h post transfection by biotin labeling of cell surface proteins, followed by precipitation of the biotin-labeled membrane proteins with streptavidin agarose beads. Western blot analysis with an anti-CXCR4 antibody demonstrated varying levels of endogenous CXCR4 plasma membrane expression that changed depending on the Cellular Physiology and Biochemistry [34] . Due to the importance of cell migration in prostate cancer metastasis, we decided to examine activation of the focal adhesion kinase (FAK) in PC3 cells expressing different Rab GTPases isoforms. Plasma membrane is needed for CXCR4 and CCR2 to bind their respective ligands; therefore, studying a signaling pathway that is known to be activated by these receptors would confirm the involvement of Rab GTPases in the regulation of the anterograde trafficking of the receptors, and of the results obtained by cell surface biotinylation. PC3 cells expressing endogenous receptors were transfected with WT and dominantnegative mutant Rab GTPases and stimulated with the CXCR4 chemokine ligand SDF-1α at a concentration of 30 ng/ml for 15 min at 37°C and 5% CO 2 (Fig. 4A) . Levels of p-FAK were then quantified with western blotting and compared between non-stimulated and stimulated cells. Results suggest that upon stimulation, there were significant decreases in FAK activation in certain dominant negative treatments compared to the Rab GTPase WT. Cells transfected with Rab2 S20N, Rab6 T27N and Rab8 T22N exhibited statistically significant (p < 0.05) differences in p-FAK activation than their WT counterparts, following SDF-1α treatment (p=0.019, 0.0001 and 0.0258, respectively). When comparing this to the cell surface assay, it is apparent that cells expressing the dominant negative mutants Rab2 S20N, Rab6 T27N and Rab8 T22N have statistically significant impairment in both CXCR4 trafficking and FAK activation following SDF-1α stimulation. Since a reduction in cell surface expression of the receptors should lead to an inhibition of downstream signal transduction, here measured as FAK activation, this result corroborates the findings of the trafficking assay.
When PC3 cells were transfected the same way, only stimulated with the CCR2 ligand MCP-1 at a concentration of 20 ng/ml for 15 min, (Fig. 4A) Rab1 S25N, Rab6 T27N , and Rab8 T22N exhibited statistically significant (p < 0.05) differences in p-FAK activation than the WT Rab GTPases, following MCP treatment (p=0.0158, 0.0231, and 0.0035, respectively; Fig.  4B ). Therefore, co-expression of Rab1 S25N, Rab6 T27N and Rab8 T22N inhibited both the expression of CCR2 at the plasma membrane and FAK activation following MCP-1 stimulation.
Next, we measured FAK activation in cells expressing the CXCR4V1/CCR2V2 heterodimer with either MCP-1 or SDF-1α to determine if there were differences from the endogenous CXCR4 or CCR2 receptors. Results from cells transfected with CXCR4V1/CCR2V2 and the Rab GTPase WTs and dominant negatives demonstrate that upon stimulation with SDF-1α, there are statistically significant (p < 0.05) decreases in p-FAK levels in cells transfected with Rab1 S25N and Rab8 T22N (p=0.0037 and 0.0078, respectively; Fig. 4C ). When PC3 cells expressing the heterodimer and GTPases were stimulated with MCP-1, they showed significant decreases in FAK phosphorylation when Rab1 and Rab8 dominant negative GTPases were expressed (p=0.0068 and 0.0329, respectively; Fig. 4D ). These results correlate 
Conclusions and Significance
Mortality resulting from the metastasis of various cancers, including prostate cancer, justifies close examination of the signal transduction pathways governing this process. Though the roles of the chemokine GPCRs CXCR4 and CCR2 are beginning to be elucidated, the role of the heterodimer is less clear. Similar studies have suggested that heterodimer trafficking itineraries and requirements may be different from each individual receptor, resulting in variable expression at the plasma membrane and subsequent differential signal transduction.
Results relating to cell surface expression of each receptor, along with the CXCR4/CCR2 heterodimer are summarized in Figure 5 . We have demonstrated that the CXCR4 receptor requires wild-type Rab2, Rab6 and Rab8 to be expressed normally at the cells surface, and unsurprisingly, requires both Rab2, Rab6 and Rab8 for proper signal transduction, measured as FAK activation. In contrast, the CCR2 receptor depends on Rab1, Rab6 and Rab8 for normal expression at the plasma membrane. Probably as a result of the reduced cell surface expression of the receptors, expression of these Rab GTPases (Rab1, Rab6 and Rab8), decreased the levels of FAK activation.
In contrast with both of the endogenous receptors, this study demonstrates that the CXCR4/CCR2 heterodimer depends on expression of wild-type Rab1 and Rab8 GTPases for proper cell surface expression. When cells expressing the heterodimer and the mutated Rab1 and Rab8 GTPases were stimulated with SDF-1 or MCP-1, there were significant reductions in FAK activation.
Taken together, these results suggest that although the individual receptors have stringent requirements for adequate signaling, the heterodimer depends a different subset of GTPase expression for proper cell surface expression and signaling. The reason for the differences in trafficking requirements between the endogenous CXCR4 and CCR2 receptors vs. heterodimer is as of yet unclear. However, these results are important in terms of developing therapeutics that could be used to prevent or slow prostate cancer metastasis. These studies support the notion that it is important to examine the anterograde trafficking schedules of heterodimeric receptors as an entity distinct from the individual receptor components. Given that the receptors in the present study are known to play a role in some of the signal transduction processes that regulate cell migration, proliferation, and survival, the anterograde trafficking of these receptors is an important aspect of the study of cancer metastasis.
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